Related Experiment Video
Updated: Feb 5, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency
Justin Beardsley1,2,3, Nhat L T Hoang1, Freddie M Kibengo4
1Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Background:
The CryptoDex trial showed that dexamethasone caused poorer clinical outcomes and slowed fungal clearance in human immunodeficiency virus-associated cryptococcal meningitis. We analyzed cerebrospinal fluid (CSF) cytokine concentrations from participants over the first week of treatment to investigate mechanisms of harm and test 2 hypotheses: (1) dexamethasone reduced proinflammatory cytokine concentrations, leading to poorer outcomes and (2) leukotriene A4 hydrolase (LTA4H) genotype influenced the clinical impact of dexamethasone, as observed in tuberculous meningitis.
Methods:
We included participants from Vietnam, Thailand, and Uganda. Using the Luminex system, we measured CSF concentrations of the following: interferon γ, tumor necrosis factor (TNF) α, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant 1, macrophage inflammatory protein 1α, and interleukin 6, 12p70, 8, 4, 10, and 17. We determined the LTA4H genotype based on the promoter region single-nucleotide polymorphism rs17525495. We assessed the impact of dexamethasone on cytokine concentration dynamics and the association between cytokine concentration dynamics and fungal clearance with mixed effect models. We measured the influence of LTA4H genotype on outcomes with Cox regression models.
Results:
Dexamethasone increased the rate TNF-α concentration's decline in (-0.13 log2pg/mL/d (95% confidence interval, -.22 to -.06 log2pg/mL/d; P = .03), which was associated with slower fungal clearance (correlation, -0.62; 95% confidence interval, -.83 to -.26). LTA4H genotype had no statistically significant impact on outcome or response to dexamethasone therapy. Better clinical outcomes were associated with higher baseline concentrations of interferon γ.
Conclusions:
Dexamethasone may slow fungal clearance and worsen outcomes by increasing TNF-α concentration's rate of decline.
Insights
Dexamethasone worsened outcomes in HIV-associated cryptococcal meningitis by increasing tumor necrosis factor-alpha (TNF-α) decline, slowing fungal clearance. Leukotriene A4 hydrolase (LTA4H) genotype did not impact outcomes.
Area of Science:
- Infectious Diseases
- Immunology
- Pharmacology
Background:
- Dexamethasone treatment for HIV-associated cryptococcal meningitis led to poorer clinical outcomes and delayed fungal clearance.
- Cerebrospinal fluid (CSF) cytokine concentrations were analyzed to understand the mechanisms behind dexamethasone's harmful effects.
- Two hypotheses were tested: dexamethasone's impact on proinflammatory cytokines and the influence of leukotriene A4 hydrolase (LTA4H) genotype.
Purpose of the Study:
- Investigate the mechanisms by which dexamethasone harms patients with HIV-associated cryptococcal meningitis.
- Determine if dexamethasone alters CSF cytokine concentrations and if these changes correlate with clinical outcomes.
- Assess whether LTA4H genotype modifies the clinical impact of dexamethasone.
Main Methods:
- CSF samples from participants in Vietnam, Thailand, and Uganda were analyzed using the Luminex system for various cytokine concentrations.
- LTA4H genotype was determined using the single-nucleotide polymorphism rs17525495.
- Mixed-effects models assessed dexamethasone's impact on cytokine dynamics and their association with fungal clearance; Cox regression models evaluated LTA4H genotype's influence on outcomes.
Main Results:
- Dexamethasone increased the decline rate of tumor necrosis factor-alpha (TNF-α) concentrations (P = .03), which correlated with slower fungal clearance (correlation, -0.62).
- No statistically significant impact of LTA4H genotype on clinical outcomes or response to dexamethasone was observed.
- Higher baseline concentrations of interferon-gamma were associated with better clinical outcomes.
Conclusions:
- Dexamethasone may impair clinical outcomes and slow fungal clearance in HIV-associated cryptococcal meningitis by accelerating TNF-α decline.
- The LTA4H genotype does not appear to influence the clinical effects of dexamethasone in this context.
- Interferon-gamma levels may serve as a potential biomarker for predicting treatment response.
More Related Videos
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
11:14Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
What are Viruses?
Atomic Radii and Effective Nuclear Charge
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Kinetic Molecular Theory and Gas Laws Explain Properties of Gas Molecules